Wrong, it was in the $2's for most of the year. It spiked to $4 for a few days in August. We have been watching this company for years. SAGE is another one that could be comparable to TAUG's holdings.
But your opinion is really mute in the scheme of things, the point that most people should take away is that one of TAUG's holdings could have explosive growth this year. $10.00 is conservative in my opinion. With what looks to be a clean safety profile and 3 potential blockbuster drugs 2019 is shaping up to be a very very interesting year.
News 
Market Data 
Discover 
